TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/3/24 18:18 | 4/1/24 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lin Shao-Lee | CA | DO | CEO | S | -66 | 6.63 | 0 | -10 | 0 | 3,452 | D | ||||||||||||||
2/22/24 19:04 | 2/20/24 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lin Shao-Lee | CA | DO | CEO | S | -119 | 7.60 | 0 | -16 | 0 | 3,462 | D | ||||||||||||||
1/4/24 18:09 | 1/2/24 | SLRN | Acelyrin, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lin Shao-Lee | CA | DO | CEO | S | -79 | 7.41 | 0 | -11 | 0 | 3,478 | D | ||||||||||||||
1/7/20 18:21 | 1/4/20 | HZNP | Horizon Therapeutics Public Ltd Co | L2 | Health | Drug | Pharmaceutical Preparations | Lin Shao-Lee | L2 | O | EVP,Head | M.dm | 0 | 0.00 | 0 | 68 | 179 | 106 | D | ||||||||||||||
1/8/19 20:40 | 1/4/19 | HZNP | Horizon Pharma Plc | DE | Health | Drug | Pharmaceutical Preparations | Lin Shao-Lee | L2 | O | EVP,Head | M.dm | 0 | 0.00 | 0 | 50 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |